Patient and Provider Opportunities
The Hepatitis B Foundation is pleased to share information about current and upcoming opportunities for people living with hepatitis B and\or D and their providers. These opportunities can be tools and resources, clinical trials, or other research opportunities to learn more from people who have hepatitis B or coinfection with delta.
A clinical research study is now enrolling adults with chronic hepatitis B virus.
Grifols is currently recruiting participants for a clinical trial for a new treatment for chronic hepatitis B virus infection. The purpose of this clinical trial is to evaluate the safety and tolerability of a single IV (intravenous) dose in part one and six IV infusions in part two of GIGA-2339 in participants with chronic HBV infection.
Your participation could contribute to research that may improve future treatment options for chronic hepatitis B.
You may be eligible to participate if you:
• Are 18+ years of age and
• Have been diagnosed with chronic HBV infection.
GIGA-2339 is an investigational drug that is designed to eliminate the hepatitis B virus particles from the blood that prevent a person’s immune system from fighting the virus. This can potentially allow the body to gain control over the infection.
The study will be conducted in two parts.
• In Part 1 a single infusion of GIGA-2339 will be given by IV and
• In Part 2 six infusions of GIGA-2339 will be given by IV every 4 weeks over the course of 6 months.
Participants will be required to stay overnight for at least 24 hours to monitor their safety and to collect blood samples after each IV infusion in both Part 1 and Part 2.
If you qualify and choose to enroll, you will be asked to attend scheduled clinic visits over a period of 105 Days for Part 1 and 245 days for Part 2.
Study-related tests may include among other assessments:
- Blood draws,
- ECG (electrocardiogram) and
- Liver ultrasound.
Study-related procedures and medications associated with this clinical trial will not result in expenses or charges to participants. Compensation for time and travel expenses may be provided.
Clinical trials provide a great opportunity to help advance hepatitis B research and give people with hepatitis B access to new treatments. To find out more information and see if you qualify, please send an email to the specific site you are interested in participating at [see the list below].
State: |
City: |
Contact information: |
|
Arizona |
Chandler, AZ, U.S. |
|
|
California |
Huntington Beach, CA, U.S. |
|
|
California |
Lake Forest, CA, U.S. |
|
|
California |
Long Beach, CA, U.S. |
|
|
California |
Oakland, CA, U.S. |
|
|
Georgia |
Peachtree Corners, GA, U.S. |
|
|
Iowa |
Iowa City, IA, U.S. |
|
|
Kansas |
Lenexa, KS, U.S. |
|
|
Virginia |
Richmond, VA, U.S. |
|
|
Texas |
San Antonio, TX, U.S. |
|
|
Texas |
Webster, TX, U.S. |
Disclaimer: Participation in this trial is completely voluntary. Your decision will not affect the medical care you receive now or in the future. Your privacy and confidentiality will be strictly maintained.
HepB PROACTive: A Multinational Quality of Life Survey
The Hepatitis B Foundation is seeking participants for a new research study titled HepB PROACTive (Hepatitis B: Patient-Reported Outcomes, Adherence and Quality of Life Tracking).
The goal of this program is to better understand the daily experiences, treatment challenges and overall well-being of individuals living with chronic hepatitis B. By sharing your story, you help us advocate for better care and support services worldwide.
Who can participate?
We are currently looking for volunteers who meet the following criteria:- Age: 18 years or older.
- Diagnosis: Living with chronic hepatitis B (HBsAg+).
- Location: Currently residing in the United States, United Kingdom, Taiwan, Nigeria, Canada or Pakistan.
Participants may also complete the survey in Traditional Chinese (繁體中文) or Simplified Chinese (简体中文).
How the study works
-
Baseline Survey: Complete an initial confidential online survey. This includes an automatic eligibility screening and an informed consent form at the start.
-
Follow-ups: To track changes over time, we will ask you to complete two brief follow-up surveys at Month 3 and Month 6.
-
Privacy: You will be asked to provide an email address solely for the purpose of receiving these follow-up links. Your information will remain confidential and will not be used to identify your individual responses.
Deadline Notice: The baseline survey must be completed by June 1, 2026
Join the program
Your voice is essential in shaping the future of hepatitis B care. Click the link below to see if you are eligible and to begin the baseline survey. Take the Quality of Life Survey [English]
The survey is also available in Traditional Chinese (繁體中文) and Simplified Chinese (简体中文).
Questions about the program? Please contact Catherine Freeland at the Hepatitis B Foundation.
Survey: Seeking youth & adolescent perspectives on hepatitis B
The Hepatitis B Foundation wants to learn about the experiences of young people with hepatitis B to improve care and support. If you or someone you know is a youth with hepatitis B, you can participate in a brief screening survey. Your insights will help inform clinicians and healthcare professionals about the unique needs of youth and adolescents.
Please sign up to participate here.
Questions? Reach out to Catherine.Freeland@hepb.org. Thank you for helping us make a difference!
Hepatitis delta research opportunity
If you are living with hepatitis delta, are at least 18 years old, and live in the United States, Mongolia, Algeria, Morocco, or Argentina, you are invited to participate in a new research opportunity! IQVIA and the Hepatitis B Foundation want to better understand the experience of living with hepatitis delta, including signs, symptoms, and impacts, to ensure that the voices of those with lived experience are included in the development of clinical trials and clinical management. This study does NOT include any treatment and will simply involve a 60-minute phone interview. You will receive compensation for your time! Share your story today - email contact@global-patients.com.
Disclaimer – The opportunities listed on this page do not represent all available opportunities. The Hepatitis B Foundation receives funding to provide information about the specific opportunities listed on this page. The Hepatitis B Foundation follows IRB-approved protocols and our own Corporate Ethics Policy for all listings. If you are interested in having an opportunity listed on this page, please email info@hepb.org.